{"nct_id":"NCT00960492","title":"Safety Study of XL184 (Cabozantinib) in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma","status":"COMPLETED","status_verified_date":"2014-09","start_date":"2009-09","start_date_type":null,"primary_completion_date":"2012-11","primary_completion_date_type":"ACTUAL","completion_date":"2013-10","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["EXEL"]}